BLOOD CANCER UNITED INC: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization: BLOOD CANCER UNITED INC (EIN 13-5644916)
Tax period: 2024-07-01 to 2025-06-30
Filed: 2026-02-27
IRS object ID: 202620589349300007
Schema version: 2024v5.5
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2026-02-27T06:22:40-06:00	ReturnTs
Tax Period End	2025-06-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	135565207	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	345 PARK AVENUE	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	101540102	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2024-07-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	135644916	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	BLOOD CANCER UNITED INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	BLOO	BusinessNameControlTxt
Phone	9149495213	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 15TH STREET NW SUITE 410	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20005	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	GORDON MILLER JR	PersonNm
Person Title	CHIEF FINANCIAL OFFICER	PersonTitleTxt
Phone	9149495213	PhoneNum
Signature	2026-02-26	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Field	Value	IRS element (for citing)
IRS Responsible Prty Info Curr	0	IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	DEVIN L DUNCAN	PreparerPersonNm
PTIN	P01249521	PTIN
Phone	2127589700	PhoneNum

Field	Value	IRS element (for citing)
Tax	2024	TaxYr
Build TS	2025-03-06 01:10:19Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	E ANDERS KOLB MD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 15TH STREET NW SUITE 410	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20005	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$606,472,218	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	BLOODCANCERUNITED.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1949	FormationYr
Legal Domicile State	NY	LegalDomicileStateCd
Activity Or Mission	CURE LEUKEMIA,LYMPHOMA,HODGKIN'S DISEASE, MYELOMA; IMPROVE QUALITY OF LIFE OF PATIENTS AND FAMILIES.	ActivityOrMissionDesc
Voting Members Governing Body	23	VotingMembersGoverningBodyCnt
Voting Members Independent	19	VotingMembersIndependentCnt
Total Employee	1390	TotalEmployeeCnt
Total Volunteers	300000	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$338,611,733	PYContributionsGrantsAmt
CY Contributions Grants	$315,334,371	CYContributionsGrantsAmt
PY Program Service Revenue	$14,932,514	PYProgramServiceRevenueAmt
CY Program Service Revenue	$16,079,272	CYProgramServiceRevenueAmt
PY Investment Income	$16,623,882	PYInvestmentIncomeAmt
CY Investment Income	$22,273,771	CYInvestmentIncomeAmt
PY Other Revenue	-$1,926,070	PYOtherRevenueAmt
CY Other Revenue	$5,011,090	CYOtherRevenueAmt
PY Total Revenue	$368,242,059	PYTotalRevenueAmt
CY Total Revenue	$358,698,504	CYTotalRevenueAmt
PY Grants And Similar Paid	$119,474,064	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$124,083,834	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$137,851,341	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$154,628,780	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$4,745,743	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$9,354,770	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$49,752,524	CYTotalFundraisingExpenseAmt
PY Other Expenses	$109,721,024	PYOtherExpensesAmt
CY Other Expenses	$110,061,092	CYOtherExpensesAmt
PY Total Expenses	$371,792,172	PYTotalExpensesAmt
CY Total Expenses	$398,128,476	CYTotalExpensesAmt
PY Revenues Less Expenses	-$3,550,113	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	-$39,429,972	CYRevenuesLessExpensesAmt
Total Assets BOY	$602,010,519	TotalAssetsBOYAmt
Total Assets EOY	$532,209,663	TotalAssetsEOYAmt
Total Liabilities BOY	$211,058,338	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$171,712,720	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$390,952,181	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$360,496,943	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	OUR MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$127,080,673	ExpenseAmt
Grant	$51,235,960	GrantAmt
Revenue	$16,079,272	RevenueAmt
Desc	A) RESEARCH PROGRAMS:AT BLOOD CANCER UNITED, WE ARE PUSHING BOUNDARIES TOWARD POWERFUL NEW THERAPIES. WE PROPEL GROUNDBREAKING CANCER TREATMENTS THROUGH ALL PHASES OF THE RESEARCH AND DRUG DEVELOPMENT PROCESS AND ARE PROUD THAT OUR SUPPORT HAS BEEN KEY TO ADVANCING 80% OF THE 153 BLOOD CANCER TREATMENT APPROVALS SINCE 2017.AS WE CONTINUED TO SUPPORT THE SEARCH FOR LIFESAVING AND LESS TOXIC TREATMENTS IN 2025, WE INVESTED IN EXCITING RESEARCH FRONTIERS, INCLUDING PRECISION MEDICINE, IMMUNOTHERAPY, AND LINKS BETWEEN MUTATIONS AND BLOOD CANCER-ADVANCEMENTS THAT ARE CHANGING THE PARADIGM OF CANCER TREATMENT. IN THE PROCESS, WE PROPELLED SEVERAL NOVEL SCIENCE INITIATIVES TO NEW HEIGHTS-MANY OF WHICH HARDLY SEEMED POSSIBLE JUST A SHORT TIME AGO.WITH ADVISORY INPUT FROM RECOGNIZED BIOMEDICAL RESEARCH EXPERTS, BLOOD CANCER UNITED FUNDED EXEMPLARY PROJECTS ACROSS THE ENTIRE RESEARCH CONTINUUM RELEVANT TO IMPROVE OUTCOMES FOR BLOOD CANCER PATIENTS, FROM BASIC LABORATORY SCIENCE THROUGH CLINICAL TRIALS, AND FROM INVESTIGATOR-INITIATED RESEARCH TO PRIVATE-SECTOR DRUG DEVELOPMENT ALLIANCES. BLOOD CANCER UNITED IS DELIBERATE AND PURPOSEFUL IN FINDING AND SUPPORTING RESEARCH THAT IS MOST LIKELY TO HELP PATIENTS AS SOON AS POSSIBLE. IN ADDITION, WHILE BLOOD CANCER UNITED DEDICATES SUBSTANTIAL FUNDING TO ADVANCING NOVEL TREATMENTS FOR BLOOD CANCER, WE RECOGNIZE THAT IT IS EQUALLY IMPORTANT THAT WE COMMIT TO IMPROVING PATIENT ACCESS TO THESE ESSENTIAL THERAPIES. TO THIS END, BLOOD CANCER UNITED ALSO SUPPORTS HEALTH SERVICES RESEARCH WORKING TO IDENTIFY BARRIERS THAT PREVENT CERTAIN PATIENTS FROM BEING ABLE TO ACCESS THE TREATMENT AND CARE THAT THEY NEED AND FINDING ACTIONABLE SOLUTIONS THAT BLOOD CANCER UNITED CAN IMPLEMENT TO OVERCOME THESE BARRIERS AND ADVANCE ITS MISSION. TO DATE, BLOOD CANCER UNITED HAS INVESTED OVER $2 BILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. OUR SUSTAINED RESEARCH INVESTMENT OVER MULTIPLE DECADES HAS PAID OFF HANDSOMELY. THIS IS BEST DEMONSTRATED BY OUR SEMINAL INVESTMENT IN CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR T) THERAPY STARTING IN 1990 THAT, SINCE 2017, HAS TRANSLATED INTO 18 FDA-APPROVALS FOR PEDIATRIC AND ADULT B-CELL ACUTE LEUKEMIA, FOR SEVERAL TYPES OF NON-HODGKIN LYMPHOMA, AND MULTIPLE MYELOMA. CAR T-CELL THERAPY HAS IN SOME CASES PRODUCED CURES IN PATIENTS WHO HAVE FAILED ALL OTHER THERAPEUTIC OPTIONS.IN FISCAL YEAR 2025, BLOOD CANCER UNITED SUPPORTED RESEARCH IN THE U.S., CANADA AND SEVERAL OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF APPROXIMATELY $81.3 MILLION. RESEARCH FUNDING WAS DISTRIBUTED ACROSS ALL BLOOD CANCERS.EQUITY IN ACCESS RESEARCH PROGRAM IN FISCAL YEAR 2022, BLOOD CANCER UNITED LAUNCHED THE EQUITY IN ACCESS RESEARCH PROGRAM, WHICH AIMS TO FUND HEALTH SERVICES RESEARCH THAT WILL GENERATE ACTIONABLE EVIDENCE TO ASSIST BLOOD CANCER UNITED IN ADVOCATING FOR CHANGES IN HEALTHCARE POLICY, DEVELOPING PATIENT-FACING PROGRAMS, AND FOSTERING PRACTICE CHANGE TO EXTEND AND IMPROVE THE LIVES OF ALL BLOOD CANCER PATIENTS. EQUITY IN ACCESS HAS AWARDED NEARLY $18 MILLION TO RESEARCHERS ADDRESSING CRITICAL ISSUES SUCH AS THE COST OF ORAL ANTICANCER MEDICATIONS, THE ROLE OF HEALTH INSURANCE IN FINANCIAL HARDSHIP, AND ACCESS FOR EVERY PATIENT TO CLINICAL TRIALS. BLOOD CANCER UNITED RECOGNIZES THE CRITICAL NEED FOR HIGH-QUALITY EVIDENCE ON INTERVENTIONS TO INCREASE PARTICIPATION IN THERAPEUTIC CANCER CLINICAL TRIALS, WHICH ARE CONSIDERED HIGH-QUALITY CANCER CARE, PARTICULARLY AMONG UNDERREPRESENTED GROUPS (E.G., PEOPLE WHO HAVE LOW INCOMES, PEOPLE WHO LIVE IN RURAL AREAS, ETHNICALLY AND RACIALLY MINORITIZED GROUPS). IN FISCAL YEAR 2025 ALONE, EQUITY IN ACCESS AWARDED NEARLY $5 MILLION TO RESEARCHERS WHO WILL IMPLEMENT AND EVALUATE NOVEL INTERVENTION APPROACHES DESIGNED TO INCREASE THERAPEUTIC CLINICAL TRIAL ENROLLMENT. THERAPY ACCELERATION PROGRAM (TAP)TAP IS BLOOD CANCER UNITED'S MISSION-DRIVEN, STRATEGIC VENTURE PHILANTHROPY INITIATIVE THAT SEEKS TO ACCELERATE THE DEVELOPMENT OF INNOVATIVE BLOOD CANCER THERAPEUTICS AND CHANGE THE STANDARD OF CARE, WHILE ALSO GENERATING A RETURN ON INVESTMENT TO CONTINUE TO SUPPORT ITS MISSION. TAP COLLABORATES WITH BIOTECH COMPANIES TO SUPPORT THE DEVELOPMENT OF NOVEL PLATFORMS AND FIRST-IN-CLASS ASSETS ADDRESSING UNMET MEDICAL NEEDS, EMERGING PATIENT POPULATIONS AND EVEN RARE BLOOD CANCERS.ESTABLISHED IN 2007, TAP HAS INVESTED MORE THAN $115 MILLION IN OVER 50 BIOTECH COMPANY PROJECTS. SINCE 2017, FIVE TAP-SUPPORTED THERAPIES HAVE BEEN APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) OR INCLUDED IN THE NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) GUIDELINES. CURRENTLY, THERE ARE OVER 30 ACTIVE CLINICAL STUDIES WITH TAP-SUPPORTED THERAPIES, INCLUDING SEVERAL REGISTRATION-ENABLING CLINICAL STUDIES IN BLOOD CANCER THAT COULD LEAD TO MORE FDA APPROVALS.IN FISCAL YEAR 2025, TAP MADE INVESTMENTS IN FIVE BIOTECH COMPANIES THAT INCLUDED THREE EXISTING BIOTECH PARTNERS AND TWO NEW UP-AND-COMING BIOTECH COMPANIES, TO HELP THEM NAVIGATE THE DRUG DEVELOPMENT LANDSCAPE AND TO SUPPORT CLINICAL TRIALS FOR BLOOD CANCER PATIENTS. SEVERAL TAP PARTNER COMPANIES ARE BASED IN EUROPE AND NOW, WITH HELP FROM TAP, THESE COMPANIES ARE RUNNING CLINICAL TRIALS IN THE US. TAP CONTINUES TO EXPAND ITS REACH AND IMPACT BY LEVERAGING ITS UNIQUE EXPERTISE TO ATTRACT MORE COMPANIES AND INVESTORS TO BLOOD CANCER DISEASES, AND TO EXPAND THE TAP INVESTMENT CAPACITY TO SUPPORT THE MOST PROMISING ASSETS.CLINICAL TRIALSBEAT AML MASTER TRIALBEGINNING NOVEMBER 2016, BLOOD CANCER UNITED LAUNCHED THE BEAT AML MASTER TRIAL, A COLLABORATIVE CLINICAL TRIAL TESTING SEVERAL NOVEL TARGETED THERAPIES FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) DESIGNED TO FACILITATE FDA APPROVAL OF NEW DRUGS AND CHANGE THE TREATMENT PARADIGM FOR PATIENTS DIAGNOSED WITH AML BY DEVELOPING MORE INDIVIDUALIZED, EFFECTIVE TREATMENT APPROACHES. THE MASTER TRIAL INVOLVES COLLABORATIONS WITH MULTIPLE MEDICAL INSTITUTIONS, DRUG COMPANIES, A GENOMIC PROVIDER, A CLINICAL RESEARCH ORGANIZATION, AND THE FDA, ALL OF WHOM HAVE COMMITTED TO WORKING COLLABORATIVELY. IN FISCAL YEAR 2025, 135 PATIENTS ENROLLED IN A SUB-STUDY UNDER THE BEAT AML MASTER TRIAL.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$123,558,480	ExpenseAmt
Grant	$72,847,874	GrantAmt
Desc	B) PATIENT & COMMUNITY SERVICES:AN ESTIMATED 1.7 MILLION PEOPLE ACROSS THE UNITED STATES (US) ARE CURRENTLY LIVING WITH OR ARE IN REMISSION FROM LEUKEMIA, LYMPHOMA, MYELOMA, MYELODYSPLASTIC SYNDROMES AND MYELOPROLIFERATIVE NEOPLASMS. BLOOD CANCER UNITED OFFERS AN ARRAY OF FREE, COMPREHENSIVE RESOURCES TO BLOOD CANCER PATIENTS, CAREGIVERS, FAMILIES AND FRIENDS OFPATIENTS, ADVOCATES, HEALTHCARE PROFESSIONALS AND THE PUBLIC. BLOOD CANCER UNITED IS COMMITTED TO PROVIDING THE MOST ACCURATE AND UP-TO-DATE BLOOD CANCER INFORMATION. PROFESSIONAL VOLUNTEER CLINICAL ADVISORS WORK WITH BLOOD CANCER UNITED STAFF TO REVIEW ALL OF THE INFORMATION BLOOD CANCER UNITED PROVIDES THROUGH HEALTHCARE PROFESSIONAL AND PATIENT EDUCATION PROGRAMS, PUBLICATIONS AND THE BLOOD CANCER UNITED WEBSITE. SUPPORT SERVICES ARE PROVIDED BY PROFESSIONALS OR RIGOROUSLY TRAINED PEER VOLUNTEERS. ALL RESOURCES ARE PROVIDED THROUGH A VARIETY OF MEDIA - PRINT, ONLINE, BY PHONE, AND FACE-TO-FACE IN COMMUNITIES. A NUMBER OF RESOURCES ARE AVAILABLE IN SPANISH FOR PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS.FINANCIAL ASSISTANCE OUR FINANCIAL ASSISTANCE PROGRAMS AIM TO LESSEN THE ECONOMIC TOLL ON PATIENTS AND FAMILIES TO HELP PATIENTS AFFORD LIFE-SAVING TREATMENTS. TO COUNTER CONTINUALLY RISING DRUG PRICES AND ALLEVIATE THE BURDENS FELT BY PATIENTS COPING WITH BLOOD CANCER, BLOOD CANCER UNITED PROVIDED 69,120 GRANTS TOTALING OVER $162M IN ASSISTANCE AWARDED. THE MAJORITY, $153M, SUPPORTED PATIENTS' INSURANCE PREMIUMS, TREATMENT-RELATED CO-PAYS, AND CO-INSURANCE OUT OF POCKET COSTS THROUGH OUR CO-PAY ASSISTANCE PROGRAM. IN KEEPING WITH OUR COMMITMENT TO DIVERSITY, EQUITY, AND INCLUSION, BLOOD CANCER UNITED RECOGNIZES THAT NEED EXISTS THROUGHOUT ALL GEOGRAPHIC REGIONS AND WITHIN ALL PATIENT POPULATIONS, INCLUDING THOSE TRADITIONALLY UNDERREPRESENTED. CO-PAY ASSISTANCE PROGRAM THE CO-PAY ASSISTANCE PROGRAM SUPPORTS QUALIFYING BLOOD CANCER PATIENTS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR BLOOD CANCER DIAGNOSIS. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH BLOOD CANCER UNITED TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUNDING AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. IN 2025, BLOOD CANCER UNITED AWARDED 35,302 GRANTS THROUGH ITS CO-PAY ASSISTANCE PROGRAM. SUSAN LANG PRE CAR T-CELL THERAPY TRAVEL ASSISTANCE PROGRAM BLOOD CANCER UNITED AWARDED 270 GRANTS EACH IN THE AMOUNT OF $2,500 FOR TREATMENT-RELATED TRANSPORTATION AND LODGING COSTS FOR PATIENTS WHO ARE BEING EVALUATED TO RECEIVE CAR T-CELL THERAPY AS EITHER STANDARD TREATMENT OR A CLINICAL TRIAL. SUSAN LANG PAY-IT-FORWARD PATIENT TRAVEL ASSISTANCE PROGRAM BLOOD CANCER UNITED AWARDED 2,040 GRANTS EACH IN THE AMOUNT OF $500 FOR TREATMENT-RELATED TRANSPORTATION AND LODGING COSTS. URGENT NEED PROGRAM IN PARTNERSHIP WITH MOPPIE'S LOVE AND CHARLIE'S FUND, BLOOD CANCER UNITED AWARDED 9,119 GRANTS EACH IN THE AMOUNT OF $500 FOR NON-MEDICAL LIVING EXPENSES-INCLUDING RENT, UTILITIES, AND FOOD. LOCAL FINANCIAL ASSISTANCE PROGRAM BLOOD CANCER UNITED AWARDED 989 GRANTS EACH IN THE AMOUNT OF $500 TO COVER NON-MEDICAL LIVING EXPENSES-INCLUDING RENT, UTILITIES, AND FOOD, ETC.PATIENT AID PROGRAM BLOOD CANCER UNITED AWARDED ONE-TIME STIPENDS OF $100 TO OVER 20,345 PATIENTS TO HELP OFFSET NON-MEDICAL EXPENSES. PATIENT AID HELENE & MILTON BLOOD CANCER UNITED AWARDED ONE-TIME STIPENDS OF $100 TO 1055 PATIENTS WHO RESIDED IN DESIGNATED ZIP CODES DECLARED FOR INDIVIDUALASSISTANCE BY FEMA, TO ALLEVIATE FINANCIAL HARDSHIP AS A RESULT OF THE HURRICANES. MEDICAL DEBT CASE MANAGEMENT PROGRAM BLOOD CANCER UNITED'S MEDICAL DEBT CASE MANAGEMENT PROGRAM PROVIDES ONE-ON-ONE, PERSONALIZED SUPPORT TO EMPOWER PATIENTS TO ADDRESS THEIR MEDICAL DEBT IN THE FOLLOWING WAYS: ADDRESS FINANCIAL CONCERNS, INCLUDING MANAGING EXISTING MEDICAL DEBT AND PLANNING FOR UPCOMING MEDICAL EXPENSES; IDENTIFY RESOURCES SUCH AS CHARITY CARE ORGANIZATIONS OR MANUFACTURER PATIENT ASSISTANCE PROGRAMS THAT MAY REDUCE THE FINANCIAL BURDEN; ASSIST WITH INSURANCE PLAN EVALUATION AND ENROLLMENT, SUCH AS MEDICAID, MEDICARE, MARKETPLACE PLANS, AND EMPLOYER-SPONSORED HEALTH INSURANCE; NAVIGATE INSURANCE BENEFITS, DENIALS OF CARE, AND OUT-OF-POCKET COSTS; AND PROVIDE SUPPORT WITH CHARITY CARE, NEGOTIATIONS, INVOICE REVIEW, ETC. THE MEDICAL DEBT CASE MANAGEMENT PROGRAM HANDLED 1579 CASES, HELPING IN THE RESOLUTION OF $3.8 MILLION IN MEDICAL DEBT BLOOD CANCER UNITED IS NOT A DEBT FORGIVENESS PROGRAM, DOES NOT PAY OFF MEDICAL DEBT, AND CANNOT ASSIST WITH DEBT THAT IS IN COLLECTIONS. PROGRAM CASE MANAGERS WORK WITH PATIENTS AND OFFER WAYS TO HELP MANAGE CURRENT DEBT AND PREVENT ACCUMULATING MORE. SCHOLARSHIP FOR BLOOD CANCER SURVIVORS IN 2025, THE BLOOD CANCER UNITED SCHOLARSHIP FOR BLOOD CANCER SURVIVORS AWARDED 285 SCHOLARSHIPS EACH UP TO $7,500 IN TUITION SUPPORT FOR VIRTUAL OR IN-PERSON VOCATIONAL, TWO-YEAR, OR FOUR-YEAR UNDERGRADUATE EDUCATION.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$28,509,773	ExpenseAmt
Desc	C) PUBLIC HEALTH EDUCATION: BLOOD CANCER UNITED BELIEVES KNOWLEDGE IS POWER. AS ALWAYS, BLOOD CANCER UNITED HAS OFFERED THEIR INFORMATIONAL PROGRAMS IN VIRTUAL FORMATS, CONTINUING TO PROVIDE VITALLY NEEDED EDUCATION AND EMOTIONAL SUPPORT FOR THOSE IMPACTED BY BLOOD CANCER. ONE-ON-ONE EDUCATION AND SUPPORTTRAINED ONCOLOGY INFORMATION SPECIALISTS IN OUR INFORMATION RESOURCE CENTER (IRC) PROVIDE PATIENTS AND CAREGIVERS WITH COMPASSIONATE, COMPREHENSIVE, AND TAILORED DISEASE AND TREATMENT INFORMATION, INCLUDING REFERRALS AND LINKS TO APPROPRIATE EDUCATIONAL RESOURCES AND LITERATURE; PSYCHOSOCIAL SUPPORT INFORMATION FOR ANY POINT IN THEIR TREATMENT JOURNEY; REFERRALS TO RELEVANT LOCAL, STATE AND/OR NATIONAL RESOURCES FOR ASSISTANCE; COVID-19 RELATED INFORMATION AND GUIDANCE; AND FINANCIAL RESOURCE INFORMATION TO COVER COSTS OF TREATMENT, TRAVEL, URGENT NEEDS AND MORE. OVER 28,000 INTERACTIONS BETWEEN THE IRC AND PATIENTS AND CAREGIVERS TOOK PLACE LAST YEAR.FACILITATING CLINICAL TRIAL ACCESSTHE BLOOD CANCER UNITED CLINICAL TRIAL SUPPORT CENTER (CTSC) CONTINUES TO EXPAND THE POSSIBILITY OF POSITIVE OUTCOMES FOR PATIENTS BY PROVIDING EDUCATION, IDENTIFYING SUITABLE CLINICAL TRIALS, AND ADDRESSING BARRIERS TO ENROLLMENT. OUR CLINICAL TRIAL NURSE NAVIGATORS ASSISTED 1158 PATIENTS AND TWENTY PERCENT OF THESE PATIENTS ENTERED A TRIAL.OUTREACH TO UNDERSERVED GROUPSWE AUGMENTED EFFORTS TO EXPAND ACCESS TO BLOOD CANCER UNITED SERVICES AND RESOURCES BY BOLSTERING RELATIONS WITH COMMUNITY GROUPS AND LEADERS, NOTABLY IN THE BLACK AND LATINO COMMUNITIES, AND INCREASED OUR NUMBER OF BILINGUAL STAFF AND VOLUNTEERS. WE ALSO INCREASED ACCESSIBILITY OF OUR EDUCATION PROGRAMS TO RURAL PATIENTS AND FAMILIES VIA OUR VIRTUAL OFFERINGS.MOREOVER, WE CONTINUED TO EXPAND PARTNERSHIPS WITH AFFINITY GROUPS, INCLUDING NATIONAL MINORITY QUALITY FORUM, NATIONAL ASSOCIATION OF RURAL HEALTH, HAIRY CELL LEUKEMIA FOUNDATION, THE BALM IN GILEAD, LATINO MEDICAL STUDENTS ASSOCIATION, IN ADDITION TO MAINTAINING RELATIONSHIPS WITH THOSE GROUPS WITH WHICH WE WERE PREVIOUSLY CONNECTED. THE BLOOD CANCER UNITED MYELOMA LINK PROGRAM, LAUNCHED IN FISCAL YEAR 2017, CONTINUED TO GAIN TRACTION.WE IMPROVED UNDERSTANDING OF TREATMENT OPTIONS BY PROVIDING IMPORTANT INFORMATION TO AFRICAN AMERICANS, WHO ARE TWICE AS LIKELY TO BE DIAGNOSED WITH MULTIPLE MYELOMA AS CAUCASIAN AMERICANS. IN FISCAL YEAR 2025, BLOOD CANCER UNITED REACHED NEARLY 21,000 PEOPLE THROUGH MYELOMA LINK NATIONAL AND REGIONAL EDUCATION AND OUTREACH ACTIVITIES IN 18 CITIES ACROSS THE U.S.IN 2025, BLOOD CANCER UNITED REACHED OVER 20,000 SPANISH-SPEAKING INDIVIDUALS NATIONWIDE THROUGH HEALTHCARE PROFESSIONAL OUTREACH, LOCAL HEALTH FAIRS, COMMUNITY EVENTS, AND OTHER GRASSROOTS ACTIVITIES. OUR NATIONAL SPANISH-LANGUAGE FACEBOOK LIVE SEGMENTS, COVERING TOPICS SUCH AS NUTRITION, MENTAL HEALTH, AND PATIENTS' RIGHTS, GARNERED OVER 1 MILLION VIEWS. WE STRENGTHENED OUR OUTREACH STRATEGY IN PUERTO RICO THROUGH EXPANDED PATIENT REFERRAL COLLABORATIONS, DEEPER HEALTHCARE PROVIDER ENGAGEMENT, AND TARGETED MEDIA PARTNERSHIPS. HIGHLIGHTS INCLUDED IMPROVING REFERRAL PROCESSES WITH MAJOR HOSPITALS, COORDINATING CO-BRANDED EDUCATION WITH THE AMERICAN CANCER SOCIETY, AND PARTNERING WITH BEHEALTHPR TO BROADEN REACH AMONG SPANISH-SPEAKING AUDIENCES. THESE EFFORTS ARE CRITICAL TO ADDRESSING SYSTEMIC ACCESS BARRIERS AND ENSURING EQUITABLE DELIVERY OF INFORMATION, NAVIGATION, AND SUPPORT SERVICES ACROSS THE ISLAND.EDUCATION AND PATIENT CONNECTIONS.OUR VIRTUAL EDUCATION PROGRAMS PROVIDED BOTH PATIENTS AND FAMILIES, AS WELL AS HEALTH CARE PROFESSIONALS, ACCESS TO CONTENT INCLUDING BLOOD CANCER CONFERENCES, LOCAL EDUCATION PROGRAMS, NATIONAL WEBINARS, VIDEOS, LECTURES, AND PODCASTS. BLOOD CANCER UNITED'S HIGHLY VIEWED WEBSITE CONTINUES TO PROVIDE THE MOST UP TO DATE BLOOD CANCER INFORMATION INCLUDING ACCESS TO BLOGS, BOOKLETS, WORKBOOKS, FACT SHEETS AND MORE. IN ADDITION, 1,754 CANCER PATIENTS WERE PROVIDED WITH PERSONALIZED NUTRITION CONSULTATIONS BY BLOOD CANCER UNITED'S REGISTERED DIETITIANS. OUR PATIENT & COMMUNITY OUTREACH TEAM CONTINUED TO BRING PATIENTS TOGETHER VIA ONLINE LOCAL SUPPORT GROUPS AND CHATS. THE PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM MATCHED 2,065 PATIENTS WITH TRAINED VOLUNTEERS WHO PROVIDE UNDERSTANDING AND SUPPORT. IN ADDITION, MEMBERSHIP IN THE BLOOD CANCER UNITED COMMUNITY - OUR ONLINE SOCIAL NETWORK - WAS 24,239, AN INCREASE OF 6% OVER FISCAL YEAR 2024.	Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

Field	Value	IRS element (for citing)
Expense	$16,653,111	ExpenseAmt
Desc	BLOOD CANCER UNITED SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. VARYING FORMATS ARE OFFERED TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT. UPCOMING AND ARCHIVED CE/CME PROGRAMS ARE AVAILABLE AT HTTPS://BLOODCANCERUNITED.ORG/RESOURCES/HEALTHCARE-PROFESSIONALSIN FY 2025:-BLOOD CANCER UNITED PROVIDED 22 CME/CE-GRANTING LIVE EDUCATIONAL PROGRAMS, WITH 2,266 HEALTHCARE PROFESSIONALS IN ATTENDANCE. IN ADDITION, 48 VIRTUAL LECTURES WERE PRESENTED WITH OVER 66,000 PARTICIPANTS.- OVER 33,000 PATIENTS AND PROFESSIONALS PARTICIPATED IN LIVE EDUCATION PROGRAMS DELIVERED VIRTUALLY AS WELL AS DELIVERED IN PERSON, LOCALLY AND REGIONALLY.--THERE WERE OVER 214,000 PAGE VIEWS FOR ARCHIVED WEB PROGRAMS, VIRTUAL LECTURES AND VIDEOS AND OVER 75,500 PODCAST DOWNLOADS. OVER 856,000 BOOKLETS AND FACT SHEETS WERE EITHER DOWNLOADED OR ORDERED IN HARD COPY.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$16,653,111	TotalOtherProgSrvcExpenseAmt
Total Program Service Expenses	$295,802,037	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	Yes (1)	CollectionsOfArtInd
Credit Counseling	Yes (1)	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (1)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	0	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (1)	ProfessionalFundraisingInd
Fundraising Activities	Yes (1)	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	Yes (1)	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	Yes (1)	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	Yes (1)	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	0	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (1)	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	Yes (1)	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (1)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	0	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	397	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	1390	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	Yes (1)	ForeignFinancialAccountInd
Foreign Country	CA	ForeignCountryCd
Foreign Country	PL	ForeignCountryCd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (1)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (1)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	0	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	23	GoverningBodyVotingMembersCnt
Independent Voting Member	19	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	Yes (1)	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	Yes (1)	LocalChaptersInd
Policies Reference Chapters	Yes (1)	PoliciesReferenceChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ID	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	LA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	GORDON MILLER JR	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Phone	9148218935	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 15TH STREET NW SUITE 410	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20005	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (37 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
ALESSANDRA TOCCO
CHAIR	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
FREDA WANG
VICE CHAIR	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
MARLA PERSKY
SECRETARY/TREASURER	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
JANICE GABRILOVE MD
AT LARGE	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
LEROY BALL
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RICHARD BAGGER
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
MARK BARRENECHEA
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RENZO CANETTA
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
M CASEY CUNNINGHAM
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
SHARON CASTELLINO
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
MIKE FARMER
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
ARI MELNICK
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
KATHLEEN MERIWETHER
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RUBEN MESA
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
LYNNE O'BRIEN
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
ALEX OKAFOR
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
JIM REDDOCH
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RICHARD RENDINA
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
ROBERT ROSEN
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RAYNE H ROUCE MD
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
JEFF SACHS
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
LILIAN STERN
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
YVETTE TREMONTI
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
E ANDERS KOLB
PRESIDENT & CEO	40.00	0.00		Yes (X)	$879,998	$0	$50,519
GWEN NICHOLS
EVP, CHIEF MED OFFICER	40.00	0.00		Yes (X)	$736,394	$0	$45,341
GORDON MILLER
EVP, CHIEF FIN OFFICER	40.00	0.00		Yes (X)	$648,480	$0	$56,317
FLORA COKER POWELL
EVP, CHIEF REV OFFICER	40.00	0.00		Yes (X)	$512,813	$0	$59,334
MEREDITH FOGEL
EVP, GEN COUNSEL - START 09/2024	40.00	0.00		Yes (X)	$312,368	$0	$54,903
SHONETTE HARRISON CAREW
EVP, CHIEF ADMIN OFF - START 09/2024	40.00	0.00		Yes (X)	$162,265	$0	$367
ORLANDO ASHWORTH
EVP, CHIEF PEOPLE - START 10/2024	40.00	0.00		Yes (X)	$95,040	$0	$562
LEE GREENBERGER
SVP, CHIEF SCI OFFICER - END 12/2024	40.00	0.00			$408,560	$0	$45,162	Yes (X)
SUSAN BROWN
SVP, CHIEF SUS OFF END - 11/12/2024	40.00	0.00			$421,797	$0	$27,278	Yes (X)
FLORENCE GODFREY
SVP, CHIEF EXPERIENCE OFFICER	40.00	0.00			$406,318	$0	$40,820	Yes (X)
ELISA WEISS
SVP, EDUCATION	40.00	0.00			$367,828	$0	$45,294	Yes (X)
ANDREW PERRY
SVP, BUS OPS AND TECHNOLOGY	40.00	0.00			$391,677	$0	$15,358	Yes (X)
DALE NISSENBAUM
FORMER EVP, GEN CNSL - END 05/2024	40.00	0.00			$547,759	$0	$15,807		Yes (X)
TROY DUNMIRE
FORMER EVP, CF OP OFF - END 01/2024	40.00	0.00			$263,181	$0	$8,453		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$6,154,478	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$465,515	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	346	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (1)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
ICON PLC - PHARMACEUTICAL RESEARCH ASSOC
4130 PARKLAKE AVENUE SUITE 400	RALEIGH	NC	27612	CLINICAL TRIAL	$9,616,721
PATIENT ADVOCATE FOUNDATION
421 BUTLER FARM RD	HAMPTON	VA	23666	PAT ASSIST PROC	$6,765,372
MOORE A SERIES LLC
4200 PARLIAMENT PLACE SUITE 300	LANHAM	MD	20706	PROFESSIONAL FUNDRAISING	$4,664,047
SALESFORCE
140 E 45TH ST	NEW YORK	NY	10017	SOFTWARE	$4,565,999
KAPADI
9650 STRICKLAND ROAD SUITE 103-150	RALEIGH	NC	27615	CLINICAL TRIAL	$3,123,545

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	175	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$355,986	FederatedCampaignsAmt
Fundraising	$139,255,682	FundraisingAmt
All Other Contributions	$175,722,703	AllOtherContributionsAmt
Noncash Contributions	$4,274,075	NoncashContributionsAmt
Total Contributions	$315,334,371	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

Field	Value	IRS element (for citing)
Desc	SERVICE REVENUE	Desc
Business	810000	BusinessCd
Total Revenue Column	$16,079,272	TotalRevenueColumnAmt
Related Or Exempt Func Income	$16,079,272	RelatedOrExemptFuncIncomeAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$16,079,272	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$19,224,485	TotalRevenueColumnAmt
Exclusion	$19,224,485	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$10,803,789	TotalRevenueColumnAmt
Exclusion	$10,803,789	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$228,293,867	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$225,244,581	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$3,049,286	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$3,049,286	TotalRevenueColumnAmt
Exclusion	$3,049,286	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$16,736,434	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$139,255,682	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$22,529,133	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$5,792,699	TotalRevenueColumnAmt
Exclusion	-$5,792,699	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$358,698,504	TotalRevenueColumnAmt
Related Or Exempt Func Income	$16,079,272	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$27,284,861	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$43,522,719	TotalAmt
Program Services	$43,522,719	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$72,847,874	TotalAmt
Program Services	$72,847,874	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$7,713,241	TotalAmt
Program Services	$7,713,241	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$3,278,438	TotalAmt
Program Services	$1,415,470	ProgramServicesAmt
Management And General	$1,459,842	ManagementAndGeneralAmt
Fundraising	$403,126	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$18,231	TotalAmt
Management And General	$18,231	ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$119,579,251	TotalAmt
Program Services	$76,835,715	ProgramServicesAmt
Management And General	$23,453,195	ManagementAndGeneralAmt
Fundraising	$19,290,341	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$3,988,177	TotalAmt
Program Services	$2,479,454	ProgramServicesAmt
Management And General	$886,340	ManagementAndGeneralAmt
Fundraising	$622,383	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$18,745,035	TotalAmt
Program Services	$11,653,810	ProgramServicesAmt
Management And General	$4,165,931	ManagementAndGeneralAmt
Fundraising	$2,925,294	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$9,019,648	TotalAmt
Program Services	$5,607,526	ProgramServicesAmt
Management And General	$2,004,543	ManagementAndGeneralAmt
Fundraising	$1,407,579	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$2,123,694	TotalAmt
Program Services	$1,274,217	ProgramServicesAmt
Management And General	$573,397	ManagementAndGeneralAmt
Fundraising	$276,080	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$419,767	TotalAmt
Management And General	$419,767	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$3,514,398	TotalAmt
Program Services	$3,514,398	ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$9,354,770	TotalAmt
Fundraising	$9,354,770	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$288,407	TotalAmt
Program Services	$221,500	ProgramServicesAmt
Management And General	$34,288	ManagementAndGeneralAmt
Fundraising	$32,619	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$24,169,211	TotalAmt
Program Services	$16,408,138	ProgramServicesAmt
Management And General	$3,981,350	ManagementAndGeneralAmt
Fundraising	$3,779,723	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$7,605,533	TotalAmt
Program Services	$4,611,440	ProgramServicesAmt
Management And General	$991,591	ManagementAndGeneralAmt
Fundraising	$2,002,502	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$14,060,991	TotalAmt
Program Services	$8,563,768	ProgramServicesAmt
Management And General	$1,398,549	ManagementAndGeneralAmt
Fundraising	$4,098,674	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$12,532,741	TotalAmt
Program Services	$944,969	ProgramServicesAmt
Management And General	$9,309,320	ManagementAndGeneralAmt
Fundraising	$2,278,452	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$3,320,960	TotalAmt
Program Services	$2,361,477	ProgramServicesAmt
Management And General	$432,198	ManagementAndGeneralAmt
Fundraising	$527,285	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$10,789,396	TotalAmt
Program Services	$8,272,676	ProgramServicesAmt
Management And General	$1,228,284	ManagementAndGeneralAmt
Fundraising	$1,288,436	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$5,125,715	TotalAmt
Program Services	$3,602,255	ProgramServicesAmt
Management And General	$726,974	ManagementAndGeneralAmt
Fundraising	$796,486	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$1,109,978	TotalAmt
Program Services	$81,399	ProgramServicesAmt
Management And General	$1,028,579	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (2 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
RESEARCH & DEVELOPMENT	$19,783,112	$19,783,112
MISCELLANEOUS	$5,217,189	$4,086,879	$461,536	$668,774

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$398,128,476	TotalAmt
Program Services	$295,802,037	ProgramServicesAmt
Management And General	$52,573,915	ManagementAndGeneralAmt
Fundraising	$49,752,524	FundraisingAmt

Field	Value	IRS element (for citing)
Joint Costs	Yes (X)	JointCostsInd

Total Joint Costs TotalJointCostsGrp

Field	Value	IRS element (for citing)
Total	$17,165,765	TotalAmt
Program Services	$13,280,340	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$3,885,425	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$3,858,985	BOYAmt
EOY	$5,202,537	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$143,907,675	BOYAmt
EOY	$96,813,180	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$45,469,673	BOYAmt
EOY	$48,116,644	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$5,836,452	BOYAmt
EOY	$9,173,907	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$29,554,477	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$19,862,721	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$10,752,233	BOYAmt
EOY	$9,691,756	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$354,480,856	BOYAmt
EOY	$330,481,970	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$22,812,891	BOYAmt
EOY	$24,669,655	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$10,615,299	BOYAmt
EOY	$6,785,419	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$316,667	BOYAmt
EOY	$116,667	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$3,959,788	BOYAmt
EOY	$1,157,928	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$602,010,519	BOYAmt
EOY	$532,209,663	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$36,559,192	BOYAmt
EOY	$33,217,287	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$155,633,120	BOYAmt
EOY	$122,193,676	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$14,667,950	BOYAmt
EOY	$14,994,156	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$4,198,076	BOYAmt
EOY	$1,307,601	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$211,058,338	BOYAmt
EOY	$171,712,720	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$251,301,743	BOYAmt
EOY	$204,762,655	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$139,650,438	BOYAmt
EOY	$155,734,288	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$390,952,181	BOYAmt
EOY	$360,496,943	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$602,010,519	BOYAmt
EOY	$532,209,663	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	-$39,429,972	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$9,453,483	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	-$478,749	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$441,317,494	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$400,540,019	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$357,670,634	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$338,611,733	CurrentTaxYearMinus1YearAmt
Current Tax Year	$315,334,371	CurrentTaxYearAmt
Total	$1,853,474,251	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$441,317,494	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$400,540,019	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$357,670,634	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$338,611,733	CurrentTaxYearMinus1YearAmt
Current Tax Year	$315,334,371	CurrentTaxYearAmt
Total	$1,853,474,251	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$444,706,475	SubstantialContributorsTotAmt
Public Support Total170	$1,408,767,776	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$16,877,123	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$18,087,763	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$13,066,416	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$18,039,091	CurrentTaxYearMinus1YearAmt
Current Tax Year	$30,028,274	CurrentTaxYearAmt
Total	$96,098,667	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$1,949,572,918	TotalSupportAmt
Gross Receipts Rltd Activities	$68,730,146	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.72260	PublicSupportCY170Pct
Public Support PY170	0.68530	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Volunteers	Yes (1)	VolunteersInd
Paid Staff Or Management	Yes (1)	PaidStaffOrManagementInd
Media Advertisements	Yes (1)	MediaAdvertisementsInd
Media Advertisements	$1,062,365	MediaAdvertisementsAmt
Mailings Members	0	MailingsMembersInd
Publications Or Broadcast	Yes (1)	PublicationsOrBroadcastInd
Publications Or Broadcast	$82,066	PublicationsOrBroadcastAmt
Grants Other Organizations	Yes (1)	GrantsOtherOrganizationsInd
Grants Other Organizations	$33,271	GrantsOtherOrganizationsAmt
Direct Contact Legislators	Yes (1)	DirectContactLegislatorsInd
Direct Contact Legislators	$1,926,174	DirectContactLegislatorsAmt
Rallies Demonstrations	0	RalliesDemonstrationsInd
Other Activities	Yes (1)	OtherActivitiesInd
Other Activities	$410,522	OtherActivitiesAmt
Total Lobbying Expenditures	$3,514,398	TotalLobbyingExpendituresAmt
Not Described Section501c3	0	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART II-B, LINE 1:	FormAndLineReferenceDesc
Explanation	BLOOD CANCER UNITED PARTICIPATES IN A NUMBER OF COALITIONS AND MEMBER ORGANIZATIONS, INCLUDING ALLIANCE FOR A STRONGER FDA, ALLIANCE FOR CHILDHOOD CANCER, ALLIANCE FOR FAIR HEALTHCARE PRICING, CANCER LEADERSHIP COUNCIL, DEFENSE HEALTH RESEARCH CONSORTIUM, MAPRX COALITION, NCSL FOUNDATION FOR STATE LEGISLATURES, ONE VOICE AGAINST CANCER, PARTNERSHIP TO PROTECT COVERAGE, PATIENT QUALITY OF LIFE COALITION, PUBLIC AFFAIRS COUNCIL, AND STATE ACCESS TO INNOVATIVE MEDICINES COALITION. EMPLOYEES IN THE BLOOD CANCER UNITED OFFICE OF PUBLIC POLICY WORK TO ADVANCE THE ORGANIZATION'S PUBLIC POLICY PRIORITIES, DOING SO WITH SUPPORT FROM LOBBYING FIRMS AND ADVISERS RETAINED BY BLOOD CANCER UNITED AND IN PARTNERSHIP WITH VOLUNTEER ADVOCATES. BLOOD CANCER UNITED VOLUNTEER ADVOCATES ENGAGE THEIR LAWMAKERS BY CONDUCTING LETTER-WRITING CAMPAIGNS, SHARING THEIR PERSONAL STORIES, AND CONDUCTING ONE-ON-ONE VISITS IN STATE CAPITOLS AND IN WASHINGTON, D.C. - ALL WITH SUPPORT FROM THE BLOOD CANCER UNITED OFFICE OF PUBLIC POLICY.	ExplanationTxt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Solicited Assets Sale	0	SolicitedAssetsSaleInd
Agent Trustee Etc	Yes (1)	AgentTrusteeEtcInd
Beginning Balance	$1,000,000	BeginningBalanceAmt
Additions During Year	$43,274	AdditionsDuringYearAmt
Ending Balance	$1,043,274	EndingBalanceAmt
Incl Escrow Custodial Acct Liab	0	InclEscrowCustodialAcctLiabInd

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$8,277,308	BeginningYearBalanceAmt
Investment Earnings Or Losses	$750,040	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$421,590	GrantsOrScholarshipsAmt
Administrative Expenses	$14,450	AdministrativeExpensesAmt
End Year Balance	$8,591,308	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,730,391	BeginningYearBalanceAmt
Contributions	$80,666	ContributionsAmt
Investment Earnings Or Losses	$787,363	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$308,062	GrantsOrScholarshipsAmt
Administrative Expenses	$13,050	AdministrativeExpensesAmt
End Year Balance	$8,277,308	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,288,293	BeginningYearBalanceAmt
Contributions	$30,000	ContributionsAmt
Investment Earnings Or Losses	$713,739	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$291,598	GrantsOrScholarshipsAmt
Administrative Expenses	$10,043	AdministrativeExpensesAmt
End Year Balance	$7,730,391	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,381,460	BeginningYearBalanceAmt
Contributions	$1,129,903	ContributionsAmt
Investment Earnings Or Losses	-$913,685	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$295,324	GrantsOrScholarshipsAmt
Administrative Expenses	$14,061	AdministrativeExpensesAmt
End Year Balance	$7,288,293	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$5,902,791	BeginningYearBalanceAmt
Contributions	$1,650	ContributionsAmt
Investment Earnings Or Losses	$1,726,314	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$236,177	GrantsOrScholarshipsAmt
Administrative Expenses	$13,118	AdministrativeExpensesAmt
End Year Balance	$7,381,460	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Prmnnt Endowment Balance EOY	0.46350	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.53650	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	0	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	0	EndowmentsHeldRelatedOrgInd

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$29,554,477	OtherCostOrOtherBasisAmt
Depreciation	$19,862,721	DepreciationAmt
Book Value	$9,691,756	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$9,691,756	TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	CAPITAL LEASE LIABILITY	Desc
Amt	$1,307,601	Amt

Field	Value	IRS element (for citing)
Total Liability	$1,307,601	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$374,017,964	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$3,049,286	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$7,631,003	DonatedServicesAndUseFcltsAmt
Other Revenue	$11,026,150	OtherRevenueAmt
Revenue Not Reported	$15,607,867	RevenueNotReportedAmt
Revenue Subtotal	$358,410,097	RevenueSubtotalAmt
Investment Expenses Not Incld	$288,407	InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt	$288,407	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$358,698,504	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$416,711,240	TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts	$7,631,003	DonatedServicesUseFcltsAmt
Other Expenses Included	$11,240,168	OtherExpensesIncludedAmt
Expenses Not Reported	$18,871,171	ExpensesNotReportedAmt
Expenses Subtotal	$397,840,069	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$288,407	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$288,407	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$398,128,476	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART III, LINE 1A:	THE BLOOD CANCER UNITED COLLECTION IS OF PHOTOGRAPHS WHICH ARE USED FOR PUBLIC EXHIBITION AT FUNDRAISING EVENTS HELD TO SUPPORT BLOOD CANCER UNITED'S PROGRAMS.
PART IV, LINE 1B:	BLOOD CANCER UNITED HELD APPROXIMATELY $1 MILLION IN ESCROW ON BEHALF OF IFLI AS PART OF A PASS-THROUGH GRANT AGREEMENT.
PART V, LINE 4:	BLOOD CANCER UNITED'S ENDOWMENTS ARE INTENDED TO FUND RESEARCH AS WELL AS SUPPORT BLOOD CANCER UNITED'S PUBLIC EDUCATION PROGRAMS.
PART X, LINE 2:	BLOOD CANCER UNITED, BLOOD CANCER UNITED RESEARCH PROGRAMS, INC., AND BLOOD CANCER UNITED RESEARCH FOUNDATION QUALIFY AS CHARITABLE ORGANIZATIONS AS DEFINED BY INTERNAL REVENUE CODE SECTION 501(C)(3) AND, ACCORDINGLY, ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER INTERNAL REVENUE CODE SECTION 501(A). BLOOD CANCER UNITED'S LIMITED LIABILITY COMPANIES ARE DISREGARDED PASS-THROUGH ENTITIES AND ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER INTERNAL REVENUE CODE SECTION 501(A). ADDITIONALLY, SINCE THESE ORGANIZATIONS ARE PUBLICLY SUPPORTED, CONTRIBUTIONS QUALIFY FOR THE MAXIMUM CHARITABLE CONTRIBUTION DEDUCTION UNDER THE INTERNAL REVENUE CODE. LLSC IS REGISTERED AS A CHARITABLE ORGANIZATION UNDER THE INCOME TAX ACT (CANADA) AND IS, THEREFORE, NOT SUBJECT TO INCOME TAXES IF CERTAIN DISBURSEMENT REQUIREMENTS ARE MET. BLOOD CANCER UNITED AND ITS RELATED ENTITIES RECOGNIZE THE EFFECT OF TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO BLOOD CANCER UNITED'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. THERE WERE NO ENTITIES THAT RECOGNIZED UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED JUNE 30, 2024 AND JUNE 30, 2025.
PART XI, LINE 2D - OTHER ADJUSTMENTS:	LLS CANADA REVENUE 11,026,150.
PART XII, LINE 2D - OTHER ADJUSTMENTS:	LLS CANADA EXPENSE 11,240,168.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)

RegionRegionTxt	OfficesOfficesCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
NORTH AMERICA	1	RESEARCH FUNDING	RESEARCH GRANTS	$1,078,560
EUROPE		RESEARCH FUNDING	RESEARCH GRANTS	$5,115,956
CENTRAL AMERICA & CARIBBEAN		INVESTMENTS	INVESTMENTS	$15,082,741
EAST ASIA & THE PACIFIC		RESEARCH FUNDING	RESEARCH GRANTS	$1,518,725
EUROPE		INVESTMENTS	INVESTMENTS	$6,568,415

Field	Value	IRS element (for citing)
Subtotal Offices	1	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	1	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$29,364,397	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$29,364,397	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (21 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$249,069	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$120,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$150,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$249,656	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$78,600	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$999,960	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$750,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$125,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$200,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$650,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$231,171	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$246,719	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$850,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$175,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	THERAPY ACCELERATION	$325,152	WIRE PAYMENT	$0	FMV
EUROPE	THERAPY ACCELERATION	$501,880	WIRE PAYMENT	$0	FMV
EUROPE	THERAPY ACCELERATION	$811,034	WIRE PAYMENT	$0	FMV

Field	Value	IRS element (for citing)
Total501c3 Org	18	Total501c3OrgCnt
Total Other Org	3	TotalOtherOrgCnt
Transfer To Foreign Corp	Yes (1)	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	Yes (1)	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	Yes (1)	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. BLOOD CANCER UNITED PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS, EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL BLOOD CANCER UNITED RECEIVES AND APPROVES THE DELINQUENT REPORT. THE ACCOUNTING METHOD UTILIZED FOR GRANTS REPORTED ON PART II IS THE ACCRUAL METHOD AS CONSISTENT WITH BOOKS AND RECORDS.	ExplanationTxt

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (1)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Organization Business Name OrganizationBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	MOORE A SERIES LLC	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	4200 PARLIAMENT PLACE SUITE 300	AddressLine1Txt
City	LANHAM	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20706	ZIPCd

Field	Value	IRS element (for citing)
Activity	DIRECT MAIL	ActivityTxt
Fundraiser Control Of Funds	0	FundraiserControlOfFundsInd
Gross Receipts	$0	GrossReceiptsAmt
Retained By Contractor	$4,664,047	RetainedByContractorAmt
Net To Organization	-$4,664,047	NetToOrganizationAmt

Field	Value	IRS element (for citing)
Total Retained By Contractors	$4,664,047	TotalRetainedByContractorsAmt
Total Net To Organization	-$4,664,047	TotalNetToOrganizationAmt
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AZ	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DE	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	ID	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	IN	LicensedStatesCd
Licensed States	IA	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	MT	LicensedStatesCd
Licensed States	NE	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	SD	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	TX	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd
Licensed States	WY	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	PR	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	LAKE TAHOE CYCLE	Event1Nm
Gross Receipts Event1	$3,086,769	GrossReceiptsEvent1Amt
Charitable Contri Event1	$2,557,137	CharitableContriEvent1Amt
Gross Revenue Event1	$529,632	GrossRevenueEvent1Amt
Non Cash Prizes Event1	$108,347	NonCashPrizesEvent1Amt
Rent Facility Costs Event1	$222,101	RentFacilityCostsEvent1Amt
Food And Beverage Event1	$6,315	FoodAndBeverageEvent1Amt
Entertainment Event1	$174,169	EntertainmentEvent1Amt
Other Direct Expenses Event1	$194,052	OtherDirectExpensesEvent1Amt
Event2	MANHATTAN WALK	Event2Nm
Gross Receipts Event2	$2,925,993	GrossReceiptsEvent2Amt
Charitable Contri Event2	$2,652,887	CharitableContriEvent2Amt
Gross Revenue Event2	$273,106	GrossRevenueEvent2Amt
Non Cash Prizes Event2	$21,124	NonCashPrizesEvent2Amt
Rent Facility Costs Event2	$236,678	RentFacilityCostsEvent2Amt
Food And Beverage Event2	$941	FoodAndBeverageEvent2Amt
Entertainment Event2	$134	EntertainmentEvent2Amt
Other Direct Expenses Event2	$14,747	OtherDirectExpensesEvent2Amt
Other Events Total	285	OtherEventsTotalCnt
Gross Receipts Other Events	$149,979,354	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$134,045,658	CharitableContriOtherEventsAmt
Gross Revenue Other Events	$15,933,696	GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events	$1,882,792	NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events	$13,848,046	RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events	$571,319	FoodAndBeverageOtherEventsAmt
Entertainment Other Events	$1,807,031	EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events	$3,441,337	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$155,992,116	GrossReceiptsTotalAmt
Charitable Contributions Tot	$139,255,682	CharitableContributionsTotAmt
Gross Revenue Total Events	$16,736,434	GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events	$2,012,263	NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events	$14,306,825	RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events	$578,575	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$1,981,334	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$3,650,136	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$22,529,133	DirectExpenseSummaryEventsAmt
Net Income Summary	-$5,792,699	NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE G, PART I, LINE 2B, COLUMN (V)	FormAndLineReferenceDesc
Explanation	BLOOD CANCER UNITED USED MOORE, A SERIES LLC FOR IT'S NATIONAL COMMUNITY CAMPAIGN AND DIRECT MAIL PROGRAMS.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (67 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH
PO BOX 026338	NEW YORK	NY	10087	131924236	501(C)(3)	$2,513,800	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF TEXAS AT AUSTIN
101 E 27TH ST	AUSTIN	TX	78712	746000203	GOVT	$250,000	$0	ACCRUAL	RESEARCH GRANT
UNC LINEBERGER COMPREHENSIVE CANCER CENTER
104 AIRPORT DRIVE	CHAPEL HILL	NC	27599	566001393	501(C)(3)	$70,000	$0	ACCRUAL	RESEARCH GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES
10889 WILSHIRE BLVD	LOS ANGELES	CA	90024	956006143	GOVT	$70,000	$0	ACCRUAL	RESEARCH GRANT
FRED HUTCHINSON CANCER CENTER
1100 FAIRVIEW AVENUE NORTH	SEATTLE	WA	98109	237156071	501(C)(3)	$1,550,000	$0	ACCRUAL	RESEARCH GRANT
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVE BELFER 1108	BRONX	NY	10461	472209056	501(C)(3)	$943,343	$0	ACCRUAL	RESEARCH GRANT
SOLU THERAPEUTICS
15 NECCO STREET	BOSTON	MA	02210	922327975		$499,999	$0	FMV	THERAPY ACCELERATION
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 EAST DUARTE ROAD	DUARTE	CA	91010	953432210	501(C)(3)	$375,000	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVENUE SOUTH SUITE 1170 AB	BIRMINGHAM	AL	35294	636005396	GOVT	$125,000	$0	ACCRUAL	RESEARCH GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
1855 FOLSOM ST	SAN FRANCISCO	CA	94103	946036493	501(C)(3)	$945,000	$0	ACCRUAL	RESEARCH GRANT
OSU FOUNDATION
1960 KENNY ROAD 4TH FLOOR	COLUMBUS	OH	43210	316025986	501(C)(3)	$579,132	$0	ACCRUAL	RESEARCH GRANT
THE OHIO STATE UNIVERSITY
1960 KENNY ROAD 4TH FLOOR	COLUMBUS	OH	43210	316025986	GOVT	$296,867	$0	ACCRUAL	RESEARCH GRANT
INDIANA UNIVERSITY
2101 E COLISEUM BLVD	FORT WAYNE	IN	46805	356001673	501(C)(3)	$504,297	$0	ACCRUAL	RESEARCH GRANT
GEORGE WASHINGTON UNIVERSITY
2121 I ST NW	WASHINGTON	DC	20052	530196584	501(C)(3)	$250,000	$0	ACCRUAL	RESEARCH GRANT
MAINE MEDICAL CENTER
22 BRAMHALL STREET	PORTLAND	ME	04102	010238552	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
RUTGERS UNIVERSITY
3 RUTGERS PLAZA	NEW BRUNSWICK	NJ	80901	226001086	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
OREGON HEALTH & SCIENCE UNIVERSITY CANCER INSTITUTE
3181 SW SAM JACKSON PARK ROAD	PORTLAND	OR	97239	237083114	501(C)(3)	$190,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF FLORIDA
33 TIGERT HALL	GAINESVILLE	FL	32611	596002052	GOVT	$2,009,874	$0	ACCRUAL	RESEARCH GRANT
VAN ANDEL RESEARCH INSTITUTE
333 BOSTWICK AVE NE	GRAND RAPIDS	MI	49503	522000820	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER
333 COTTMAN AVENUE	PHILADELPHIA	PA	19111	232003072	501(C)(3)	$620,000	$0	ACCRUAL	RESEARCH GRANT
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE	CINCINATTI	OH	45229	310833936	501(C)(3)	$500,541	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF PENNSYLVANIA DEPARTMENT OF MEDICINE
3451 WALNUT STREET FRANKLIN BLDG	PHILADELPHIA	PA	19104	231352685	501(C)(3)	$104,214	$0	ACCRUAL	RESEARCH GRANT
PERELMAN SCHOOL OF MEDICINE AT THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREET FRANKLIN BLDG	PHILADELPHIA	PA	19104	231352685	GOVT	$640,000	$0	ACCRUAL	RESEARCH GRANT	P-221
THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
350 COMMUNITY DR	MANHASSET	NY	11030	112673595	501(C)(3)	$250,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF PITTSBURGH
4200 FIFTH AVE	PITTSBURGH	PA	10526	250965591	GOVT	$120,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
4301 WEST MARKHAM ST	LITTLE ROCK	AR	72205	716046242	GOVT	$250,000	$0	ACCRUAL	RESEARCH GRANT
DANA-FARBER CANCER INSTITUTE INC
450 BROOKLINE AVENUE	BOSTON	MA	02215	042263040	501(C)(3)	$5,197,687	$0	ACCRUAL	RESEARCH GRANT
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
450 SERRA MALL	STANFORD	CA	94305	941156365	501(C)(3)	$2,257,440	$0	ACCRUAL	RESEARCH GRANT
SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE	SEATTLE	WA	98105	911156519	501(C)(3)	$249,999	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF WISCONSIN AT MADISON
500 LINCOLN DR	MADISON	WI	53715	396006492	GOVT	$73,600	$0	ACCRUAL	RESEARCH GRANT
DURHAM VA MEDICAL CENTER
508 FULTON STREET	DURHAM	NC	27705	741612229	501(C)(3)	$500,000	$0	ACCRUAL	RESEARCH GRANT
NEW YORK COLUMBIA UNIVERSITY MEDICAL CENTER
535 W 116TH ST	NEW YORK	NY	10027	135598093	501(C)(3)	$1,173,600	$0	ACCRUAL	RESEARCH GRANT
AURON THERAPEUTICS
55 CHAPEL ST	NEWTON	MA	02458	823865673		$500,000	$0	FMV	THERAPY ACCELERATION
NYU GROSSMAN SCHOOL OF MEDICINE
550 FIRST AVENUE	NEW YORK	NY	10016	135562309	501(C)(3)	$245,940	$0	ACCRUAL	RESEARCH GRANT
JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
575 LEXINGTON AVE	NEW YORK	NY	10022	131623978	501(C)(3)	$2,115,000	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF CHICAGO
5841 S MARYLAND AVE MC6092	CHICAGO	IL	60637	362177139	GOVT	$123,600	$0	ACCRUAL	RESEARCH GRANT
RHODE ISLAND HOSPITAL
593 EDDY STREET	PROVIDENCE	RI	02903	050258954	501(C)(3)	$125,000	$0	ACCRUAL	RESEARCH GRANT
THE JACKSON LABORATORY
600 MAIN STREET	BAR HARBOR	ME	04609	010211513	501(C)(3)	$155,000	$0	ACCRUAL	RESEARCH GRANT
NORTHWESTERN UNIVERSITY
633 CLARK AVE	EVANSTON	IL	60208	362167817	501(C)(3)	$157,406	$0	ACCRUAL	RESEARCH GRANT
VERSITI BLOOD CENTER OF WISCONSIN
638 N 18TH ST	MILWAUKEE	WI	53233	390807235	501(C)(3)	$37,500	$0	ACCRUAL	RESEARCH GRANT
HOUSTON METHODIST RESEARCH INSTITUTE
6670 BERTNER AVENUE	HOUSTON	TX	77030	870721923	501(C)(3)	$500,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF SOUTHERN CALIFORNIA
700 CHILDS WAY	LOS ANGELES	CA	90089	951642394	GOVT	$239,560	$0	ACCRUAL	RESEARCH GRANT
WASHINGTON UNIVERSITY IN ST LOUIS
700 ROSEDALE AVENUE	ST LOUIS	MO	63112	430653611	501(C)(3)	$2,252,023	$0	ACCRUAL	RESEARCH GRANT
ATRIUM HEALTH FOUNDATION
7800 PROVIDENCE RD	CHARLOTTE	NC	28226	566060481	501(C)(3)	$125,110	$0	ACCRUAL	RESEARCH GRANT
TEXAS A&M UNIVERSITY HEALTH SCIENCE CENTER
8441 RIVERSIDE PKWY	BRYAN	TX	77807	742907553	GOVT	$250,000	$0	ACCRUAL	RESEARCH GRANT
THE MEDICAL COLLEGE OF WISCONSIN
8701 W WATERTOWN PLANK RD	MILWAUKEE	WI	53226	390806261	GOVT	$375,000	$0	ACCRUAL	RESEARCH GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE MC 0009	LA JOLLA	CA	92093	956006144	GOVT	$370,000	$0	ACCRUAL	RESEARCH GRANT
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA MEDICAL CENTER
OFFICE OF RESEARCH SERVICES	PHILADELPHIA	PA	19104	231352685	GOVT	$1,069,925	$0	ACCRUAL	RESEARCH GRANT
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
ONE GUSTAVE L LEVY PLACE	NEW YORK	NY	10029	136171197	501(C)(3)	$253,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF CALIFORNIA AT DAVIS
ONE SHIELDS AVE	DAVIS	CA	95616	946036494	GOVT	$250,000	$0	ACCRUAL	RESEARCH GRANT
YALE UNIVERSITY
PO BOX 1873	NEW HAVEN	CT	06520	060646973	501(C)(3)	$664,225	$0	ACCRUAL	RESEARCH GRANT
BAYLOR COLLEGE OF MEDICINE
PO BOX 301207	DALLAS	TX	75303	741613878	501(C)(3)	$370,000	$0	ACCRUAL	RESEARCH GRANT
EMORY UNIVERSITY
PO BOX 935084	ATLANTA	GA	31193	582137993	501(C)(3)	$1,661,071	$0	ACCRUAL	RESEARCH GRANT
ST JUDE CHILDREN'S RESEARCH HOSPITAL
PO BOX 1000 DEPT 949	MEMPHIS	TN	38148	620646012	501(C)(3)	$1,308,000	$0	ACCRUAL	RESEARCH GRANT
VANDERBILT UNIVERSITY MEDICAL CENTER
PO BOX 121236	DALLAS	TX	75312	620476822	501(C)(3)	$424,913	$0	ACCRUAL	RESEARCH GRANT
THE BRIGHAM AND WOMENS HOSPITAL INC
PO BOX 3149	BOSTON	MA	02241	042312909	501(C)(3)	$150,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF VIRGINIA
PO BOX 400195	CHARLOTTESVILLE	VA	22904	237173411	GOVT	$999,997	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF MIAMI
PO BOX 405803	ATLANTA	GA	30384	590624458	GOVT	$1,280,887	$0	ACCRUAL	RESEARCH GRANT
BOSTON CHILDREN'S HOSPITAL
PO BOX 414413	BOSTON	MA	02241	042774441	501(C)(3)	$750,000	$0	ACCRUAL	RESEARCH GRANT
MASSACHUSETTS GENERAL HOSPITAL
PO BOX 414876	BOSTON	MA	02241	041564655	501(C)(3)	$1,073,600	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
PO BOX 4266	HOUSTON	TX	77210	746001118	GOVT	$2,518,448	$0	ACCRUAL	RESEARCH GRANT
DUKE UNIVERSITY MEDICAL CENTER
PO BOX 602651	CHARLOTTE	NC	28260	560532129	501(C)(3)	$194,691	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF COLORADO DENVER ANSCHUTZ MEDICAL CAMPUS
PO BOX 6508	AURORA	CO	80045	846000555	GOVT	$1,966,500	$0	ACCRUAL	RESEARCH GRANT
H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
PO BOX 742801	ATLANTA	GA	30374	593238634	501(C)(3)	$1,312,498	$0	ACCRUAL	RESEARCH GRANT
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
PO BOX 8500	PHILADELPHIA	PA	19178	231352166	501(C)(3)	$284,000	$0	ACCRUAL	RESEARCH GRANT
MAYO CLINIC ROCHESTER
PO BOX 860334	MINNEAPOLIS	MN	55486	416011702	501(C)(3)	$125,000	$0	ACCRUAL	RESEARCH GRANT
VETERANS HEALTH FOUNDATION
UNIVERSITY DR	PITTSBURGH	PA	15240	251666090	501(C)(3)	$50,000	$0	ACCRUAL	RESEARCH GRANT

Field	Value	IRS element (for citing)
Total501c3 Org	65	Total501c3OrgCnt
Total Other Org	2	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (9 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt
COPAY ASSISTANCE CLL	12007	$24,198,796
COPAY ASSISTANCE LYMPHOMA	7712	$19,535,615
COPAY ASSISTANCE MDS	1507	$524,688
COPAY ASSISTANCE MYELOMA	7297	$6,469,725
COPAY ASSISTANCE MANTEL	722	$1,526,820
COPAY ASSISTANCE WALDENST	470	$1,127,345
COPAY ASSISTANCE AML	5587	$8,932,351
PATIENT TRAVEL ASSISTANCE	2310	$1,744,037
PATIENT AID	35250	$9,103,963

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. BLOOD CANCER UNITED PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS, EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL BLOOD CANCER UNITED RECEIVES AND APPROVES THE DELINQUENT REPORT. PATIENT FINANCIAL AID: BLOOD CANCER UNITED REGULARLY RECEIVES CALLS FROM PATIENTS WHO CANNOT MOVE FORWARD WITH THEIR POTENTIALLY LIFE-SAVING TREATMENTS BECAUSE THEY CANNOT AFFORD TO PAY FOR MANY EXPENSES RELATED TO THEIR TREATMENT. SOMETIMES PATIENTS HAVE TO CHOOSE BETWEEN BASIC NEEDS SUCH AS FOOD OR SHELTER AND THEIR HEALTH CARE TREATMENT EXPENSES. IN AN EFFORT TO ALLEVIATE SUCH HARDSHIPS, BLOOD CANCER UNITED HAS ESTABLISHED A PATIENT FINANCIAL AID PROGRAM THAT PROVIDES APPLICANTS, WHO RESIDE IN THE US AND HAVE A BLOOD CANCER DIAGNOSIS, A ONE-TIME ANNUAL STIPEND OF HELP DEFER SOME OF THESE EXPENSES. BLOOD CANCER UNITED ROUTINELY CONDUCTS AN OPERATIONAL AUDIT VERIFYING APPLICANTS ARE IN COMPLIANCE WITH PROGRAM GUIDELINES AND PROGRAM CRITERIA. CO-PAY ASSISTANCE: PATIENT APPLICATIONS ARE PROCESSED ON A FIRST COME, FIRST SERVED BASIS. ELIGIBLE PATIENTS MUST RESIDE IN THE UNITED STATES OR PUERTO RICO, HAVE A PROGRAM COVERED BLOOD CANCER DIAGNOSIS CONFIRMED BY A PHYSICIAN, MAINTAIN MEDICAL/PRESCRIPTION INSURANCE AND HAVE HOUSEHOLD INCOME AT OR BELOW 500% OF THE US FEDERAL POVERTY LEVEL AS ADJUSTED BY HOUSEHOLD SIZE AND COST OF LIVING INDEX. PATIENTS MUST PROVIDE PROOF OF INSURANCE AND INCOME. QUALIFYING PATIENTS ARE APPROVED FOR A TWELVE MONTH COVERAGE PERIOD. PATIENT TRAVEL ASSISTANCE: BLOOD CANCER UNITED REGULARLY RECEIVES CALLS FROM PATIENTS WHO CANNOT MOVE FORWARD WITH THEIR POTENTIALLY LIFE-SAVING TREATMENTS BECAUSE THEY CANNOT AFFORD TO PAY FOR TRANSPORTATION TO GET TO THEIR PROVIDERS, E.G. DOCTORS, HOSPITALS, TRANSPLANT CENTERS, AND RESEARCH OR CLINICAL TRIAL CENTERS. SOMETIMES PATIENTS HAVE TO TRAVEL OUT-OF-STATE TO GET THEIR PRESCRIBED AND RECOMMENDED TREATMENTS, OFTEN TIMES RESULTING IN PATIENTS HAVING TO CHOOSE BETWEEN BASIC NEEDS SUCH AS FOOD OR SHELTER AND THEIR HEALTH CARE. IN AN EFFORT TO ALLEVIATE SUCH HARDSHIPS, BLOOD CANCER UNITED ESTABLISHED THE TRAVEL ASSISTANCE PROGRAM WHICH PROVIDES APPLICANTS, WHO ARE US CITIZENS OR PERMANENT RESIDENTS, HAVE AN ANNUAL INCOME AT OR BELOW 500% OF THE FEDERAL POVERTY LEVEL (FPL) AND HAVE A CONFIRMED BLOOD CANCER DIAGNOSIS, A ONE-TIME ANNUAL STIPEND TO HELP DEFER SOME OF THESE EXPENSES. BLOOD CANCER UNITED ROUTINELY CONDUCTS AN OPERATIONAL AUDIT VERIFYING APPLICANTS ARE IN COMPLIANCE WITH PROGRAM GUIDELINES AND PROGRAM CRITERIA.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (1)	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (13 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
E ANDERS KOLB
PRESIDENT & CEO	$678,834	$0	$200,000	$0	$1,164	$0	$4,982	$0	$45,537	$0	$930,517	$0	$0	$0
GWEN NICHOLS
EVP, CHIEF MED OFFICER	$466,269	$0	$105,142	$0	$164,983	$0	$17,250	$0	$28,091	$0	$781,735	$0	$0	$0
GORDON MILLER
EVP, CHIEF FIN OFFICER	$404,089	$0	$90,964	$0	$153,427	$0	$17,250	$0	$39,067	$0	$704,797	$0	$0	$0
FLORA COKER POWELL
EVP, CHIEF REV OFFICER	$433,238	$0	$57,711	$0	$21,864	$0	$17,250	$0	$42,084	$0	$572,147	$0	$0	$0
DALE NISSENBAUM
FORMER EVP, GEN CNSL - END 05/2024	$397,356	$0	$0	$0	$150,403	$0	$5,933	$0	$9,874	$0	$563,566	$0	$0	$0
LEE GREENBERGER
SVP, CHIEF SCI OFFICER - END 12/2024	$346,235	$0	$47,558	$0	$14,767	$0	$17,250	$0	$27,912	$0	$453,722	$0	$0	$0
SUSAN BROWN
SVP, CHIEF SUS OFF END - 11/12/2024	$375,110	$0	$46,513	$0	$174	$0	$12,075	$0	$15,203	$0	$449,075	$0	$0	$0
FLORENCE GODFREY
SVP, CHIEF EXPERIENCE OFFICER	$343,837	$0	$61,550	$0	$931	$0	$12,220	$0	$28,600	$0	$447,138	$0	$0	$0
ELISA WEISS
SVP, EDUCATION	$323,795	$0	$43,058	$0	$975	$0	$17,250	$0	$28,044	$0	$413,122	$0	$0	$0
ANDREW PERRY
SVP, BUS OPS AND TECHNOLOGY	$331,055	$0	$59,723	$0	$899	$0	$12,075	$0	$3,283	$0	$407,035	$0	$0	$0
MEREDITH FOGEL
EVP, GEN COUNSEL - START 09/2024	$264,771	$0	$46,707	$0	$890	$0	$16,040	$0	$38,863	$0	$367,271	$0	$0	$0
TROY DUNMIRE
FORMER EVP, CF OP OFF - END 01/2024	$263,176	$0	$0	$0	$5	$0	$1,464	$0	$6,989	$0	$271,634	$0	$0	$0
SHONETTE HARRISON CAREW
EVP, CHIEF ADMIN OFF - START 09/2024	$112,033	$0	$50,000	$0	$232	$0	$0	$0	$367	$0	$162,632	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 7	FormAndLineReferenceDesc
Explanation	BLOOD CANCER UNITED AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO EMPLOYEE PERFORMANCE AND ORGANIZATION TARGETS. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2,PART II, COL (B) (II).	ExplanationTxt

Schedule L IRS990ScheduleL

Grnt Asst Bnft Interested Prsn GrntAsstBnftInterestedPrsnGrp (3 entries)

Relationship With OrgRelationshipWithOrgTxt	Cash GrantCashGrantAmt	Type Of AssistanceTypeOfAssistanceTxt	Assistance PurposeAssistancePurposeTxt
SHARON CASTELLINO
BOARD MEMBER	$150,000	GRANTS	RESEARCH GRANT
ARI MELNICK
BOARD MEMBER	$1,500,000	GRANTS	RESEARCH GRANT
RAYNE ROUCE
BOARD MEMBER	$300,000	GRANTS	RESEARCH GRANT

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

Field	Value	IRS element (for citing)
Person	SHEENA MEHTA	PersonNm

Field	Value	IRS element (for citing)
Relationship Description	DAUGHTER-IN-LAW OF BOARD MEMBER OF JANICE GABRILOVE	RelationshipDescriptionTxt
Transaction	$18,231	TransactionAmt
Transaction	COMPENSATION	TransactionDesc
Sharing Of Revenues	0	SharingOfRevenuesInd

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	253	ContributionCnt
Noncash Contributions Rpt F990	$4,246,606	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FAIR MARKET VALUE	MethodOfDeterminingRevenuesTxt

Food Inventory FoodInventoryGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	3	ContributionCnt
Noncash Contributions Rpt F990	$6,379	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FAIR MARKET VALUE	MethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp (2 entries)

Non Cash CheckboxNonCashCheckboxInd	DescDesc	ContributionContributionCnt	Noncash Contributions Rpt F990NoncashContributionsRptF990Amt	Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)	VARIOUS OTHER	19	$18,490	FAIR MARKET VALUE
Yes (X)	PRINTED ITEMS	1	$2,600	FAIR MARKET VALUE

Field	Value	IRS element (for citing)
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (1)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	0	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE M - SUPPLEMENTAL INFORMATION PART I, COLUMN B	FormAndLineReferenceDesc
Explanation	BLOOD CANCER UNITED IS REPORTING THE NUMBER OF CONTRIBUTIONS FOR EACH OF THE ITEMS IN PART I, NOT THE NUMBER OF INDIVIDUAL ITEMS.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 4	ALL OF BLOOD CANCER UNITEDS BYLAWS AND CHARTERS WERE CHANGED FROM LEUKEMIA AND LYMPHOMA SOCIETY TO BLOOD CANCER UNITED AS PART OF AN ORGANIZATION-WIDE NAME CHANGE. NO OTHER CHANGES WERE MADE.
FORM 990, PART VI, SECTION B, LINE 11B	THE FORM 990 WAS PREPARED BY THE BLOOD CANCER UNITED'S FINANCE DEPARTMENT AND WAS REVIEWED BY THE CFO, SENIOR VICE PRESIDENT OF FINANCE, VICE PRESIDENT, CONTROLLER, AND KPMG FOR COMMENT AND SUGGESTED REVISIONS. THE FORM 990 WAS THEN PROVIDED TO THE AUDIT COMMITTEE, WHICH IS A COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWED THE 990 AND PROVIDED INPUT PRIOR TO FILING. THE FINAL DRAFT FORM 990, AS WILL BE FILED WITH THE IRS, WAS PROVIDED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12C	ALL BLOOD CANCER UNITED KEY PERSONS ARE REQUIRED TO COMPLETE ANNUAL CONFLICT OF INTEREST DISCLOSURE STATEMENTS. OTHER LLS REPRESENTATIVES ARE ENCOURAGED TO DISCLOSE POTENTIAL CONFLICTS AND MAY BE REQUIRED TO COMPLETE DISCLOSURE STATEMENTS WHEN REQUESTED. ALL DISCLOSURE STATEMENTS ARE REVIEWED BY THE LEGAL DEPARTMENT AND ESCALATED TO THE AUDIT COMMITTEE FOR EVALUATION AND MANAGEMENT OF ACTUAL OR POTENTIAL CONFLICTS OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	THE TALENT AND COMPENSATION COMMITTEE, COMPRISED OF INDEPENDENT BOARD MEMBERS, ESTABLISHES COMPENSATION GUIDELINES AND RECOMMENDS CEO COMPENSATION TO THE EXECUTIVE COMMITTEE BASED ON PERFORMANCE EVALUATIONS AND MARKET STUDIES. THE EXECUTIVE COMMITTEE ESTABLISHES CEO PERFORMANCE GOALS AND CONDUCTS EVALUATIONS. THE EXECUTIVE COMMITTEE MAKES FINAL RECOMMENDATIONS TO THE BOARD FOR APPROVAL, WITH ALL DECISIONS DOCUMENTED IN COMMITTEE MINUTES. THE LAST EVALUATION WAS NOVEMBER 2024.
FORM 990, PART VI, SECTION C, LINE 19	BLOOD CANCER UNITED MAKES ITS ANNUAL FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS WEBSITE AT BLOODCANCERUNITED.ORG. ITS GOVERNING DOCUMENTS ARE MADE AVAILABLE UPON REQUEST FOR PUBLIC INSPECTION. ANY IDENTIFIED CONFLICTS OF INTEREST ARE DISCLOSED IN THE 990.
FORM 990, PART XI, LINE 9:	FOREIGN CURRENCY ADJUSTMENTS -478,749.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (16 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
BEAT AML LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	NY	$6,984,125	$712,731	BLOOD CANCER UNITED
PEDAL BCU LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	NY	$11,534,579	$1,634,650	BLOOD CANCER UNITED
TAP BCU LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE	-$1,112,729	$9,770,672	BLOOD CANCER UNITED
TAP BCU AURON LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
TAP BCU KDAC LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
TAP BCU KURA LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
TAP BCU CONSTELLATION LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
TAP BCU KYMERA LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
TAP BCU MIRAGEN LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
TAP BCU SOLU LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
TAP BCU CROSSBOW LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
TAP BCU X4 LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
MISSION ASSETS LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
MISSION ASSETS - MCG LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
RESEARCH RETURNS LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED
JLSA3 RR LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			BLOOD CANCER UNITED

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1ForeignAddress/AddressLine1Txt	CityForeignAddress/CityNm	CountryForeignAddress/CountryCd	Foreign PostalForeignAddress/ForeignPostalCd	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile Foreign CountryLegalDomicileForeignCountryCd	Direct Controlling NADirectControllingNACd	Controlled OrganizationControlledOrganizationInd	Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
THE LLS OF CANADA
804 2 LANSING SQUARE	TORONTO	CA	M2J4P8	BLOOD CANCER RESERACH	CA	N/A	0
BLOOD CANCER UNITED RESEARCH FOUNDATION
				SUPPORTS BLOOD CANCER UNITED			Yes (1)	1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	133709252	DE	501(C)(3)	LINE 12A, I	BLOOD CANCER UNITED INC
BLOOD CANCER UNITED RESEARCH PROGRAMS INC
				SUPPORTS BLOOD CANCER UNITED			Yes (1)	1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	133470494	DE	501(C)(3)	LINE 12A, I	BLOOD CANCER UNITED INC

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	0	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	0	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	0	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	0	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	0	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	0	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	0	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	0	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	0	SharingOfFacilitiesInd
Paid Employees Sharing	0	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	0	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (1)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd